Celldex Therapeutics

Goal disorientation and lack of vision
Biotech

Celldex ends esophageal program despite hitting primary endpoint

The biotech showed the candidate depletes mast cells in the GI tract, but that positive finding was overshadowed by its failure to improve symptoms.
Nick Paul Taylor Aug 20, 2025 6:42am
reshuffle pipeline target reorganize shift change

Celldex drops phase 1 tumor bispecific to focus on inflammation

Nov 7, 2024 7:25am
target reach ladder climb meet win beat competition

Celldex anti-cKIT antibody reduces hives in another phase 2 test

Jul 30, 2024 5:50am
soccer kick off ball football field play game crowd boots cleats

Celldex laces up next to Big Pharmas with chronic hive drug

Nov 6, 2023 10:17am
stock chart

After cancer flops, Celldex shows promise in treating hives

Jul 12, 2021 8:05am
Human T cell

Novel two-drug combo teaches immune system to attack cancer

Apr 8, 2019 11:00am